Bafna Pharmaceuticals Share Price
Know More₹152.90 2.10 (1.39%)
04:01 PM, 2-Jan-2026₹151.15 2.76 (1.86%)
03:47 PM, 2-Jan-2026BSE : 532989
NSE : BAFNAPH
Sector : Health care
ISIN Code : INE878I01022
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 02-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 362 |
Traded Value (₹ Cr) | 0.01 |
Volume (Shares) | 855 |
Face Value (₹) | 10 |
52-Week High (₹) | 204.95 |
52-Week High Date | 12-Nov-2025 |
52-Week Low (₹) | 67.80 |
52-Week Low Date | 18-Feb-2025 |
All Time High (₹) | 204.95 |
All Time High Date | 12-Nov-2025 |
All Time Low (₹) | 4.65 |
All Time Low Date | 23-Aug-2019 |
Bafna Pharmaceuticals Ltd
Market News
Bafna Pharma. Announcement
Bafna Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 358 |
| EPS - TTM (₹) [C] | 0.00 |
| P/E Ratio (X) [C] | - |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 6.00 |
| Latest Dividend Date | 19-Sep-2013 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 21.61 |
| P/B Ratio (₹) [C] | 6.99 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Data Not Found | |||
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 145.35 152.50 |
| Week Low/High (₹) | 145.00 172.00 |
| Month Low/High (₹) | 137.48 173.00 |
| Year Low/High (₹) | 69.00 202.00 |
| All time Low/High (₹) | 4.65 234.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -7.95% | -7.58% | 0.85% | 1.10% |
| 1 Month | -2.80% | -0.03% | 0.73% | 1.14% |
| 3 Month | -12.12% | -12.49% | 5.90% | 6.01% |
| 6 Month | 67.15% | 65.73% | 2.82% | 3.44% |
| 1 Year | 80.05% | 83.01% | 7.28% | 8.85% |
| 3 Year | 50.85% | 48.19% | 40.21% | 44.68% |
Company Info
Company Information
Whole Time Director : Shanmugam Hemalatha
Non-Executive & Non-Independent Director : Akilapriya Chandrashekar Raju
Non Executive & Independent Director : Ravichandran Chitra
Non Executive Director : Upendar Mekala Reddy
Whole-time Director : Vinayak Dinesh Dendukuri
Company Sec. & Compli. Officer : A Mohanachandran
Additional Director : Navin Kumar
Non Executive Director : Palamadai Krishnan Sundaresan
Registered Office: Bafna Towers New No 68, Old No 299 Thambu Chetty St,Chennai,Tamil Nadu-600001 Ph: 91-44-25267517/25270992/4267755
FAQs about Bafna Pharmaceuticals Ltd
1. What's the Bafna Pharmaceuticals Ltd share price today?
Bafna Pharmaceuticals Ltd share price was Rs 152.90 at 04:01 PM IST on 2nd Jan 2026. Bafna Pharmaceuticals Ltd share price was up by 1.39% over the previous closing price of Rs 150.80. Bafna Pharmaceuticals Ltd share price trend:
- Last 1 Month: Bafna Pharmaceuticals Ltd share price moved down by 2.80% on BSE.
- Last 3 Months: Bafna Pharmaceuticals Ltd share price moved down by 12.12% on BSE.
- Last 12 Months: Bafna Pharmaceuticals Ltd share price moved up by 80.05% on BSE.
- Last 3 Years: Bafna Pharmaceuticals Ltd share price moved up by 50.85% on BSE.
2. How can I quickly analyse the performance of the Bafna Pharmaceuticals Ltd stock?
The performance of the Bafna Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- Price to book value ratio is 6.99
3. What is the market cap of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd has a market capitalisation of Rs 362 crore.
4. What is Bafna Pharmaceuticals Ltd's 52-week high/low share price?
The Bafna Pharmaceuticals Ltd’s 52-week high share price is Rs 204.95 and 52-week low share price is Rs 67.80.
5. Is the Bafna Pharmaceuticals Ltd profitable?
On a consolidated basis, Bafna Pharmaceuticals Ltd reported a loss of Rs -0.59 crore on a total income of Rs 12.16 crore for the quarter ended 2019.
6. Which are Bafna Pharmaceuticals Ltd’s peers in the Health care sector?
Bafna Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Trident Lifeline, Kerala Ayurveda, Valiant Laborato, Bafna Pharma., Gennex Lab., Zim Laboratories, Lyka Labs.
7. Who owns how much in Bafna Pharmaceuticals Ltd?
Key changes to the Bafna Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Bafna Pharmaceuticals Ltd has gone down to 75.00 per cent as of Sep 2025 from 88.30 per cent as of Dec 2024.
